FOLH1 and metastatic malignant neoplasm in the lymph nodes: Recently, Gafita et al. [33] reported that patients having concomitant bone and lymph node metastases have poorer OS following [177Lu]Lu-PSMA RLT compared to those with only lymph node metastases (HR: 1.39).